Basics Tarsus Pharmaceuticals, Inc. Common Stock IPO Date: October 12, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.99B Activated in VL: True Average Daily Range Avg Daily Range: $0.76 | 2.71% Avg Daily Range (30 D): $1.31 | 2.17% Avg Daily Range (90 D): $0.99 | 1.92% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .58M Avg Daily Volume (90 D): .53M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 46 Institutional Trades Total Inst.Trades: 1,359 Avg Inst. Trade: $2.75M Avg Inst. Trade (30 D): $2.7M Avg Inst. Trade (90 D): $3.13M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.94M Avg Closing Trade (30 D): $4.76M Avg Closing Trade (90 D): $4.5M Avg Closing Volume: 78.56K     News Oct 1, 2025 @ 5:00 PM Lyme Disease Market Growth Highlighted by Pipeline... Source: Delveinsight Aug 27, 2025 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: Tarsus Pharmaceuticals, Inc. Aug 27, 2025 @ 8:26 AM 3 Biotech Catalysts Present Major Opportunity Source: Nathan Reiff Jul 30, 2025 @ 9:00 PM Tarsus to Report Second Quarter 2025 Financial Res... Source: Tarsus Pharmaceuticals, Inc. May 29, 2025 @ 9:00 PM Tarsus to Participate in Upcoming Investor Confere... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.32 $-.48 $-.64 Diluted EPS $-2.32 $-.48 $-.64 Revenue $ 295.52M $ 102.66M $ 78.34M Gross Profit $ $ $ Net Income / Loss $ -91.99M $ -20.34M $ -25.12M Operating Income / Loss $ -98.05M $ -22.18M $ -26.28M Cost of Revenue $ $ $ Net Cash Flow $ -81.88M $ -79.14M $ 80.97M PE Ratio